Sh2,500.00
Azithromycin 500mg (sold under the brand name Azicure) is an antibiotic medication used to treat bacterial infections in different parts of the body.
Here are some of the specific uses of Azithromycin 500mg (Azicure):
| Settings | remove | Aciclovir 200mg Tablets remove | Aciclovir Skin Cream remove | AMBROSAN SYRUP AMBROXOL 100ML remove | Atenolol 50 Anol remove | Ascard 75 Tablets remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh2,500.00 | Sh15,000.00 | Sh2,000.00 | Sh3,000.00 | Sh4,000.00 | Sh3,000.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description | Azithromycin 500mg (sold under the brand name Azicure) is an antibiotic medication used to treat bacterial infections in different parts of the body. |
|
| |||
| Content |
Here are some of the specific uses of Azithromycin 500mg (Azicure):
| Aciclovir 200 mg Tablets contain a medicine called aciclovir. This belongs to a group of medicines called antivirals. It works by killing or stopping the growth of viruses. | Aciclovir belongs to a class of medication known as antivirals. It works by stopping the growth of the virus. This medication does not cure herpes, and it does not prevent passing the infection to someone else. It does not prevent a future occurrence. | Prescribed for various respiratory diseases such as
| Anol 50mg Tablet belongs to a group of medicines called beta-blockers. It is used to treat high blood pressure (hypertension), angina (heart-related chest pain), irregular heart rhythms (arrhythmia). It also helps to prevent future heart attacks and stroke and migraines. | Ascard belongs to the category of Anti-platelet and Anti-coagulant drugs. It prevents blood clots and helps the blood in flowing smoothly. It is primarily used for the prevention of cardiovascular diseases and to relieve muscle aches, toothaches, and headaches. |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.